Selective biocatalytic mono-hydroxylation of synthetic building blocks
A novel enzymatic process using cytochrome P450s for efficient, selective mono-hydroxylation of synthetic building blocks. Offers cost-effective, scalable alternatives to traditional chemical methods.
Overview
Selective biocatalytic mono-hydroxylation of synthetic building blocks is a breakthrough technology utilizing oxidative enzymes, specifically cytochrome P450s, to efficiently and selectively hydroxylate compounds. This innovative approach addresses the challenges of achieving regioselectivity and preventing further oxidation, common issues in traditional chemical hydroxylation methods. The technology offers a cost-effective, scalable solution particularly valuable for industries requiring precise chemical modifications, such as pharmaceuticals and agrochemicals.
Technical specifications
Key features:
- Utilizes cytochrome P450 enzymes known for their high selectivity in benzylic and ortho-hydroxylation.
- Provides a single-step process for mono-hydroxylation with ≥95% selectivity.
- Initial experiments utilize isolated enzymes, followed by whole-cell biocatalysts with E. coli expressing the desired CYP450.
- Analytical techniques such as GC/MS used to determine product formation and identity.
Technology readiness level
This technology is currently at TRL 2, indicating that it is at the proof-of-concept stage in a lab environment. Future validation plans include developing reaction conditions and scaling the process using whole-cell biocatalysts, with a projected budget and timeline in place for further development.
About Wageningen University and Research
Wageningen University & Research is a life sciences–focused public university combined with mission-driven research institutes, integrating fundamental, applied, and field-based R&D at scale. On Wageningen Campus, companies co-locate with WUR teams and use shared pilot plants, advanced analytical labs, and controlled‑environment facilities for rapid prototyping. Being in the Food Valley cluster provides tight links to global corporates, SMEs, and startups through living labs and a strong regional talent pipeline. Research is backed by competitive funding from the Dutch Research Council, European Union programs, and national ministries, alongside significant contract research for industry. A dedicated technology transfer office and campus incubators streamline IP, licensing, and spin‑out formation for corporate partners and entrepreneurs.
delivered to your inbox.